Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 41, Issue 1, 2001, Pages 69-74

  Costello, Michael F ^a   Hughes, Graeme J ^a   Garrett, Don K ^a   Steigrad, Stephen J ^b   EkangaM, Abie ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONCEPTION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PATIENT COUNSELING; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0035092679     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2001.tb01297.x     Document Type: Article

References (13)

1. The incidence, characteristics and prognosis of patients whose infertility is unexplained
2. The value of menotropin treatment for unexplained infertility prior to an in-vitro fertilization attempt
3. Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: A prospective, nonrandomized, cohort study and meta-analysis
4. Unexplained infertility
5. Human menopausal gonadotrophins in the treatment of unexplained infertility
6. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome
7. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
8. Prognostic value of day 3 estradiol on in vitro fertilization outcome
9. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization
10. Elevated levels of basal estradiol-17 beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization
11. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy
12. The menopausal transition: Endocrinological and epidemiological considerations
13. Reproductive aging: Accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women